The BRAF V600E mutation is common in thyroid cancer, ovarian cancer, etc. Among 68 ligands in the Davis database, 22 ligands target wild-type BRAF and/or BRAF V600E mutants with different binding affinities, as shown in Figure 3A. This evidence concerns the gene BRAF and thyroid gland carcinoma.